Subconjunctival Rituximab Administration for the Treatment of Scleritis
Sign Up to like & getrecommendations! Published in 2022 at "Ocular Immunology and Inflammation"
DOI: 10.1080/09273948.2022.2029498
Abstract: ABSTRACT Purpose Scleritis is a sight-threatening inflammation, which is commonly accompanied by severe complications. Aggressive systemic immunosuppressive treatment, which is frequently needed, can be associated with serious complications, and might therefore be (temporarily) contraindicated. Methods… read more here.
Keywords: scleritis; administration treatment; subconjunctival rituximab; treatment ... See more keywords